Latest Ratios: P/E Ratio 57.8x · EV/EBITDA N/A · ROE 4.6%. (2024–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Market Cap | $399M | $187M | — |
| Enterprise Value | $398M | $187M | — |
| P/E Ratio → | 57.84 | 41.18 | — |
| P/S Ratio | — | — | — |
| P/B Ratio | 0.97 | 0.69 | — |
| P/FCF | — | — | — |
| P/OCF | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| EV / Revenue | — | — | — |
| EV / EBITDA | — | — | — |
| EV / EBIT | — | — | — |
| EV / FCF | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Gross Margin | — | — | — |
| Operating Margin | — | — | — |
| Net Profit Margin | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| ROE | 4.6% | 4.6% | — |
| ROA | 4.4% | 4.4% | -0.1% |
| ROIC | -0.6% | -0.6% | — |
| ROCE | -0.8% | -0.8% | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Debt / Equity | — | — | — |
| Debt / EBITDA | — | — | 57813.89 |
| Net Debt / Equity | — | -0.00 | — |
| Net Debt / EBITDA | — | — | 41626.00 |
| Debt / FCF | — | — | — |
| Interest Coverage | — | — | — |
Net cash position: cash ($624163) exceeds total debt ($0)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Current Ratio | 0.89 | 0.89 | 0.01 |
| Quick Ratio | 0.89 | 0.89 | 0.01 |
| Cash Ratio | 0.75 | 0.75 | — |
| Asset Turnover | — | — | — |
| Inventory Turnover | — | — | — |
| Days Sales Outstanding | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Dividend Yield | — | — | — |
| Payout Ratio | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Earnings Yield | 1.7% | 2.4% | — |
| FCF Yield | — | — | — |
| Buyback Yield | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | — | — |
| Shares Outstanding | — | $18M | $5000 |
Target acquisition failure risk
According to recent financial filings, CGCT trades at a P/B ratio of 0.97, suggesting that the market is pricing the entity at a slight discount to its net asset value, which serves as a critical floor for investors during the ongoing search for a business combination.
The P/E ratio of 57.84 is largely non-informative given the absence of core operating revenue and the reliance on non-operating interest income. Investors should interpret this valuation as a reflection of the sponsor's reputation and the time-value of the capital held in trust rather than an assessment of underlying business performance.
Based on reported figures, CGCT's ROE of 0.6% in 2026Q1 highlights the marginal returns generated by the trust account, which are currently being eroded by the administrative expenses required to maintain the shell entity and conduct due diligence on potential acquisition targets.
The negative ROIC of -0.2% indicates that the capital deployed for search activities is not yet generating a productive return, which is expected for a pre-revenue SPAC. This trend warrants further investigation into whether the sponsor can improve capital efficiency as the search duration approaches its mandatory liquidation deadline.
As reported in the 2026Q1 financial statements, the current ratio has deteriorated to 0.37, indicating that the company's immediate working capital is insufficient to cover its short-term liabilities without relying on external sponsor support or additional financing to sustain its ongoing search for a target.
The quick ratio of 0.37 mirrors the current ratio, confirming that the entity lacks liquid assets outside of the restricted trust account to meet its operational obligations. This liquidity profile suggests a vulnerable position that may force management to prioritize deal closure over optimal acquisition terms.
The most commonly misapplied metric for CGCT is the P/E ratio, which obscures the reality that the company is a pre-revenue shell entity whose net income is driven by non-operating interest gains rather than sustainable operational earning power or core business growth.
Analysts should instead focus on the 'Redemption Rate' and 'Trust Account Yield' as primary indicators of the vehicle's health. Relying on traditional profitability ratios for a SPAC is misleading, as these metrics fail to account for the impending reverse recapitalization that will fundamentally alter the company's financial profile.
Includes 30+ ratios · 2 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CGCT stock.
Cartesian Growth Corporation III's current P/E ratio is 57.8x. The historical average is 41.2x. This places it at the 100th percentile of its historical range.
Cartesian Growth Corporation III's return on equity (ROE) is 4.6%. The historical average is 4.6%.
Based on historical data, Cartesian Growth Corporation III is trading at a P/E of 57.8x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.